ADPT
Adaptive Biotechnologies Corporation
NASDAQ · Healthcare · Biotechnology · US
$24.28
−1.18%Margins
Gross margin
75.4%
EBITDA margin
-5.2%
EBIT margin
-12.2%
Net margin
-20.7%
FCF margin
-7.8%
-44.7%
Return on equity
-10.0%
Return on assets
-6.8%
Return on invested capital
0.54x
Asset turnover
-$21.0M
Cash from operations
$2.16
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026